Fertility Awareness · Biomarkers
Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1
Leiva R, McNamara-Kilian M, Niezgoda H, Ecochard R, Bouchard T
Cite this paper
Leiva, R., McNamara-Kilian, M., Niezgoda, H., Ecochard, R., & Bouchard, T. (2019). Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1. BMJ Open, 9(5), e028496. https://doi.org/10.1136/bmjopen-2018-028496
Leiva R, McNamara-Kilian M, Niezgoda H, Ecochard R, Bouchard T. Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1. BMJ Open. 2019;9(5):e028496. doi:10.1136/bmjopen-2018-028496
Leiva, Rene, et al. "Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1." BMJ Open, vol. 9, no. 5, 2019, pp. e028496.
For EndNote, Zotero or Mendeley:
Open access
No open license is recorded for this paper. Reuse terms are set by the publisher.
Open Access
Free full text on PubMed Central (PMC6538017)


